Cargando…
Short Term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?
Multi-cancer early detection tests are precipitating a re-examination of potential short-term endpoints for cancer screening trials. A reduction in advanced stage incidence is a prime candidate, and stage-shift models that substitute early-stage for late-stage survival have been used to predict mort...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335323/ https://www.ncbi.nlm.nih.gov/pubmed/37259797 http://dx.doi.org/10.1158/1055-9965.EPI-22-1307 |